Literature DB >> 22766367

Perioperative mortality after pancreatectomy: a risk score to aid decision-making.

Elizaveta Ragulin-Coyne1, James E Carroll, Jillian K Smith, Elan R Witkowski, Sing Chau Ng, Shimul A Shah, Zheng Zhou, Jennifer F Tseng.   

Abstract

BACKGROUND: Undergoing a pancreatectomy obligates the patient to risks and benefits. For complex operations such as pancreatectomy, the objective assessment of baseline risks may be useful in decision-making. We developed an integer-based risk score estimating in-hospital mortality after pancreatectomy, incorporating institution-specific mortality rates to enhance its use.
METHODS: Pancreatic resections were identified from the Nationwide Inpatient Sample (1998-2006), and categorized as proximal, distal, or nonspecified by the International Classification of Diseases, 9th edition. Logistic regression and bootstrap methods were used to estimate in-hospital mortality using demographics, diagnosis, comorbidities (Charlson index), procedure, and hospital volume; 80% of this cohort was selected randomly to create the score and 20% was used for validation. Score assignments were subsequently individually fitted to risk distributions around specific mortality rates.
RESULTS: Sixteen thousand one hundred sixteen patient discharges were identified. Nationwide in-hospital mortality was 5.3%. Integers were assigned to predictors (age group, Charlson index, sex, diagnosis, pancreatectomy type, and hospital volume) and applied to an additive score. Three score groups were defined to stratify in-hospital mortality (national mortality, 1.3%, 4.9%, and 14.3%; P < .0001), with sufficient discrimination of derivation and validation sets (C statistics, 0.72 and 0.74). Score groups were shifted algorithmically to calculate risk based on institutional data (eg, with institutional mortality of 2.0%, low-, medium-, and high-risk patient groups had 0.5%, 1.9%, and 5.4% mortality, respectively). A web-based tool was developed and is available online (http://www.umassmed.edu/surgery/panc_mortality_custom.aspx).
CONCLUSION: To maximize patient benefit, objective assessment of risk for major procedures is necessary. We developed a Surgical Outcomes Analysis and Research risk score predicting pancreatectomy mortality that combines national and institution-specific data to enhance decision-making. This type of risk stratification tool may identify opportunities to improve care for patients undergoing specific operative procedures.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22766367     DOI: 10.1016/j.surg.2012.05.018

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  An Evaluation of Artificial Neural Networks in Predicting Pancreatic Cancer Survival.

Authors:  Steven Walczak; Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2017-08-03       Impact factor: 3.452

2.  External assessment of the Early Mortality Risk Score in patients with adenocarcinoma undergoing pancreaticoduodenectomy.

Authors:  Gaëtan-Romain Joliat; David Petermann; Nicolas Demartines; Markus Schäfer
Journal:  HPB (Oxford)       Date:  2015-04-23       Impact factor: 3.647

3.  A Multicenter, Randomized Controlled Trial of Perioperative Palliative Care Surrounding Cancer Surgery for Patients and Their Family Members (PERIOP-PC).

Authors:  Rebecca A Aslakson; Shivani V Chandrashekaran; Elizabeth Rickerson; Bridget N Fahy; Fabian M Johnston; Judith A Miller; Alison Conca-Cheng; Suwei Wang; Arden M Morris; Karl Lorenz; Jennifer S Temel; Thomas J Smith
Journal:  J Palliat Med       Date:  2019-09       Impact factor: 2.947

Review 4.  Surgery for pancreatic ductal adenocarcinoma.

Authors:  R Vera; L Díez; E Martín Pérez; J C Plaza; A Sanjuanbenito; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-23       Impact factor: 3.405

Review 5.  Mortality factors in pancreatic surgery: A systematic review. How important is the hospital volume?

Authors:  Richard Hunger; Barbara Seliger; Shuji Ogino; Rene Mantke
Journal:  Int J Surg       Date:  2022-05-04       Impact factor: 13.400

6.  Utilising advance care planning videos to empower perioperative cancer patients and families: a study protocol of a randomised controlled trial.

Authors:  Rebecca A Aslakson; Sarina R Isenberg; Norah L Crossnohere; Alison M Conca-Cheng; Ting Yang; Matthew Weiss; Angelo E Volandes; John F P Bridges; Debra L Roter
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

7.  Prediction of in-hospital mortality after pancreatic resection in pancreatic cancer patients: A boosting approach via a population-based study using health administrative data.

Authors:  Jose F Velez-Serrano; Daniel Velez-Serrano; Valentin Hernandez-Barrera; Rodrigo Jimenez-Garcia; Ana Lopez de Andres; Pilar Carrasco Garrido; Alejandro Álvaro-Meca
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

8.  Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.

Authors:  M Hidalgo; R Álvarez; J Gallego; C Guillén-Ponce; B Laquente; T Macarulla; A Muñoz; M Salgado; R Vera; J Adeva; I Alés; S Arévalo; J Blázquez; A Calsina; A Carmona; E de Madaria; R Díaz; L Díez; T Fernández; B G de Paredes; M E Gallardo; I González; O Hernando; P Jiménez; A López; C López; F López-Ríos; E Martín; J Martínez; A Martínez; J Montans; R Pazo; J C Plaza; I Peiró; J J Reina; A Sanjuanbenito; R Yaya; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2016-12-19       Impact factor: 3.405

9.  Frailty is a useful predictive marker of postoperative complications after pancreaticoduodenectomy.

Authors:  Yutaka Nakano; Yuki Hirata; Tatsuya Shimogawara; Toru Yamada; Koki Mihara; Ryo Nishiyama; Shin Nishiya; Hideki Taniguchi; Tomohisa Egawa
Journal:  World J Surg Oncol       Date:  2020-08-03       Impact factor: 2.754

10.  Factors leading to pancreatic resection in patients with pancreatic cancer: a national perspective.

Authors:  David T Pointer; Zaid Al-Qurayshi; John B Hamner; Douglas P Slakey; Emad Kandil
Journal:  Gland Surg       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.